Respiratory
1 drug is in development for Alpha 1-Antitrypsin Deficiency.
- Companies
- 1
- Clinical trials
- 12
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Alpha 1-Antitrypsin Deficiency pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| belcesiran | Dicerna Pharmaceuticals Inc (DRNA) |
About this indication
Alpha 1-Antitrypsin Deficiency context
Respiratory·MeSH: alpha 1-Antitrypsin Deficiency (D019896)
Also known as: Deficiencies, alpha 1-Antitrypsin
Frequently asked questions
How many drugs are in development for Alpha 1-Antitrypsin Deficiency?
BioSniper tracks 1 drug in development for Alpha 1-Antitrypsin Deficiency across 1 company.
How many clinical trials target Alpha 1-Antitrypsin Deficiency?
There are 12 clinical trials targeting Alpha 1-Antitrypsin Deficiency tracked by BioSniper.